Summary Development of thermotolerance is an important phenomenon that must be considered when thermochemotherapy with multiple heat treatments is used clinically. To study the effect of thermotolerance on cellular cisplatin (cDDP) sensitivity at 3rC and 43-C in cell lines with different cDDP sensitivities, two Ehrlich ascites tumour cell lines (one with high cDDP sensitivity and one with in vitro acquired cDDP resistance) were used. The results indicate that in both cell lines the state of thermotolerance per se did not affect the cDDP sensitivity at 37C. Thus, general elevations in 'all' heat shock protein levels as found in thermotolerant cells apparently do not influence cDDP sensitivity to a considerable extent. The sensitising effect of a (second) heat treatment given simultaneously with a cDDP treatment was less in thermotolerant cells. Thermal enhancement ratios (TERs) at the 10% survival level for heat doses of 43VC for 30 min or 43VC for 60 min were reduced by a factor of 1.6 and 2.1 in cDDP-resistant and -sensitive thermotolerant cells respectively, as compared with control cells. Thus, protection against heat damage in thermotolerant cells seems to be paralleled by diminished thermal chemosensitisation. Although the effect of thermotolerance on the cDDP-sensitising effect was less pronounced in the resistant cells, a modifying effect on the resistance factor was not achieved.
dichloroplatinum(II)] is a major limitation to the clinical success of the drug. The subject of cDDP resistance has been extensively studied in vitro (reviewed by Andrews and Howell, 1990) , and is most likely a multifactorial phenomenon. Decreased cellular drug accumulation, enhanced drug detoxification by glutathione or metallothioneins, reduced DNA damage induction and elevated DNA repair capacity are among the mechanisms reported to contribute to decreased sensitivity in cDDP-resistant cell lines.
Hyperthermia has been shown to enhance the cytotoxic action of a number of chemotherapeutic drugs (reviewed by Engelhardt, 1987) , including cDDP. Since hyperthermia has the potential to interfere with all the above-mentioned mechanisms that can cause cDDP resistance, it may also be a suitable modality to interfere with acquired resistance. The studies performed so far on hyperthermic cDDP sensitisation in cDDP-resistant cell lines seem to indicate that, at least with higher temperatures (i.e. 43°C), drug resistance may be overcome partially (Wallner et al., 1986; Herman et al., 1988; Mansouri et al., 1989; Konings et al., 1993; Hettinga et al., 1994) .
For the clinical use of thermochemotherapy, optimal treatment schedules of heat and the chemotherapeutic agent must be determined. If fractionated treatments are given, the development of thermotolerance is an important phenomenon to be considered. Thermotolerance, first described by Gerner and Schneider (1975) , is the transient resistant state of cells to a (second) heat treatment after being pre-exposed to hyperthermia. For successful use of thermochemotherapy it is important to know whether the thermotolerant state influences the cDDP sensitivity of cells at 37C. In thermotolerant cells elevated levels of heat shock proteins (HSPs) have been found. These HSPs seem to play an important role in thermal resistance (for review see Morimoto et al., 1990) . Transfection studies with HSPs show that transfectants have increased resistance to heat (Landry et al., 1989; Li et al., 1991) . HSPs may also influence sensitivity to cytostatic drugs. Transfectants with the human small heat shock protein HSP27 have been shown to exhibit a multidrug-resistant phenotype (Huot et al., 1991) Figure 3 the cDDP sensitivity at 37C of the EN and ER control and thermotolerant cells (5 h after thermotolerance induction) is shown. At the 10% survival level the control ER cells are 4.8 times as resistant to the drug as the control EN cells. The thermotolerant cells of both cell lines were more sensitive to cDDP treatment at 37C than the control cells.
To determine whether this increased sensitivity was due to the state of thermotokrance or to a persisting sensitiing effect of the 10 min at 44-C treatment to trigger thermotoleance, the cDDP sensitivity was investigated by separating the trigger beat dose (10 min at 44-C) and the cDDP treatment by 0-8 h incubation at 37C. Figure 2 ) does not appear to affect the cells' sensitivity to cDDP to a great extent.
Hyperthermic cDDP sensitisation in control and thermotolerant EN and ER cells Figure 5 shows the cDDP-sensitising effect of different heat treatments (5min at 44'C. 30min at 43YC. 60min at 42°C) with about the same level of cell kill within one cell line. As can be seen, these different time-temperature combinations have, in parallel with the same cell k-illing effect, the same cDDP-sensitising effect. This was found to be the case in both the EN (Figure 5a ) and ER cells (Figure 5b ). Thus, these data are suggestive of a correlation between heat killing and thermal drug sensitisation. This would imply that, if the killing effect of a certain heat treatment is decreased, for instance by induction of thermotolerance, the sensitising effect would be expected to be lower too. at 43C. cDDP survival curves were constructed and are shown in Figure 6 . From these curves TERs of the 43-C heat treatments were calculated and are depicted in Figure 7 . As can be deduced from this figure, the sensitising effect of 30 or 60 min of 43-C hyperthermia in both EN (Figure 7a ) and ER (Figure 7b ) thermotolerant cells was found to be decreased significantly by a factor of 2.1 and 1.6 respectively.
Dcoss cDDP sensitivity at 37eC of thermotolerant cells It is known (Wallner et al., 1986; Eichholtz-Wirth and Hietel, 1990 ) that when combined treatments of heat and cDDP are given, maximal potentiation is observed when both modalities are given simultaneously; the interaction gradually decreases to the additive level when heat and cDDP are separated by incubation at 37C. This was also observed in the present study (Figure 4c) . was observed any more. At this time the cells have become quite resistant to heat toxicity ( Figure Ic) because of thermotolerance development. Since the cDDP sensitivity of the cells is equal to the sensitivity of control cells at this time point, the state of thermotolerance does not seem to confer resistance against cDDP toxicity to the cells. Unaltered cDDP sensitivity at 37'C in thermotolerant cells is in accordance with previously published data of both in vitro (Neilan et al., 1986; Miller et al., 1989; Majima et al., 1992 ) and in vivo (Yano et al., 1993) studies. Also, absence of interaction of thermotolerance with the cytotoxicity of several other drugs was observed, e.g. bleomycin toxicity has been shown to be unaltered in thermotolerant cells in a number of studies (Morgan et al., 1979; Neilan et al., 1986; Majima et al., 1992 (Morgan et al., 1979; Herman et al., 1982; Neilan et al., 1986; Majima et al., 1992 Burgman and Konings, 1992) . This leads to, among other things, an increase in the protein mass of nuclei isolated from heated cells (Roti-Roti and Wimward, 1978) . Under several conditions, including thermotolerance, a good correlation has been found between the extent and duration of this so-caled nuclear protein aggregation and thermal cell rilling (Kampinga et al., 1989a) . This nuclear protein aggregation may also be one of the major mechanisms responsible for thermal potentiation of killing by a number of drugs, by hampering repair of drug-induced DNA damage. Therefore, reduced protein aggregation or accelerated disag tion, as observed (Kampinga et al., 1987 (Kampinga et al., , 1989a Wallen and Landis, 1990; Borelli et al., 1992; Laszlo, 1992) 
